Gyrus Capital

Gyrus Capital is a Geneva-based private equity firm that pursues transformational investments in European mid-market companies operating in life sciences, healthcare, sustainability and technology. It focuses on growth capital and turnaround opportunities, typically targeting enterprises valued from about €30 million to €300 million, and seeks majority or significant minority stakes to support strategic changes and value creation.

Robert Watson Ph.D

Co-Founder and Partner

6 past transactions

ACBC

Acquisition in 2025
ACBC is a sustainable footwear company that produces modular shoes with interchangeable soles and uppers. They also manufacture shopping bags and sandals using materials like leather and natural fibers.

Neo Medical

Series B in 2024
Neo Medical SA is a medical technology company based in Villette, Switzerland, with additional offices in Germany, France, and the United States. Founded in 2013, the company specializes in developing, manufacturing, and commercializing non-constraint thoraco-lumbar spinal fusion systems for spinal surgery. Its flagship product, the Neo Pedicle Screw System, offers a range of functionalities such as reduction, compression, distraction, and screw augmentation, addressing various pathologies including degenerative conditions, tumors, and trauma. Neo Medical aims to enhance the efficiency of healthcare delivery by providing versatile and high-quality surgical solutions, thereby contributing to the ongoing pursuit of healthcare cost optimization.

Consulcesi Group

Acquisition in 2022
Consulcesi Group is a European network dedicated to supporting healthcare professionals through a range of digital solutions. The company partners with healthcare providers to offer access to essential resources, including training courses, health insurance, and legal support. By facilitating these services, Consulcesi Group aims to bridge the gap between healthcare companies and professionals, enhancing their operational efficiency and professional development.

Katalist Group

Acquisition in 2022
Katalist Group is a software implementation and consulting business serving the food wholesale and pharmaceutical sectors.

LivaNova - Heart Valve Business

Acquisition in 2020
The LivaNova HV business is a global player in surgical heart valves with world-class products and compelling growth opportunities.

Essential Pharma Group

Acquisition in 2020
Essential Pharma (EP) ensures the sustainable supply of low volume, difficult to manufacture but clinically well-established pharmaceutical products to patients. These branded and generic medicines form an essential part of the pharmacopeia and represent many therapeutic areas. The company is an important partner to healthcare providers by providing medicines that otherwise would not be available.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.